# Clinical trials recruiting in Massachusetts: 3,429 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 3,429 trials recruiting or not yet recruiting with a site in Massachusetts, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Massachusetts: 3,429 rows for $114.29, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 56 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/massachusetts

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 3,429
- Recruiting or not yet: 3,429
- Read on: November 19, 2026

## Trials

The 25 newest of 3,429, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946315 | Tirzepatide for the REduction of AceTazolamide in Idiopathic Intracranial Hypertension | Brigham and Women's Hospital | Phase 2 | Not yet recruiting | Idiopathic Intracranial Hypertension (IIH), Pseudotumor Cerebri, Papilledema | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946315) |
| November 17, 2026 | NCT07940712 | Cognitive Augmentation, Remediation, and TDCS for Schizophrenia | Beth Israel Deaconess Medical Center | Not applicable | Not yet recruiting | Schizophrenia / Schizoaffective Disorder | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940712) |
| November 16, 2026 | NCT07940335 | Lithium Dosing Study | Massachusetts General Hospital | Not applicable | Not yet recruiting | Cognitive Impairment, Dementia, Alzheimer Disease | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940335) |
| November 16, 2026 | NCT07939841 | N-Acetylcysteine (NAC) in Primary Sclerosing Cholangitis (PSC) | Brigham and Women's Hospital | Phase 2 | Not yet recruiting | Primary Sclerosing Cholangitis (PSC) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939841) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 16, 2026 | NCT07938632 | TL-925 for the Treatment of Allergic Conjunctivitis | Telios Pharma, Inc. | Phase 2 | Not yet recruiting | Allergic Conjunctivitis of Both Eyes | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938632) |
| November 16, 2026 | NCT07938463 | Lorlatinib Plus TNG462 in ALK+ MTAP Del NSCLC | Dana-Farber Cancer Institute | Phase 1 | Not yet recruiting | ALK Positive Non-small Cell Lung Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938463) |
| November 16, 2026 | NCT07938164 | ACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis... | ANI Pharmaceuticals | Phase 4 | Recruiting | Acute Gouty Arthritis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938164) |
| November 16, 2026 | NCT07937696 | A Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome | National Cancer Institute (NCI) | Phase 2 | Not yet recruiting | Colorectal Carcinoma, EPCAM Lynch Syndrome, Lynch Syndrome, MLH1 Lynch Syndrome, MSH2 Lynch Syndrome, MSH6 Lynch... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937696) |
| November 13, 2026 | NCT07936396 | Creating Mobility-supported Home Play Environments to Enhance Development in Infants With Down Syndrome | Boston University Charles River Campus | Not applicable | Not yet recruiting | Down Syndrome | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936396) |
| November 13, 2026 | NCT07935317 | A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast Cancer | Eli Lilly and Company | Phase 2 | Not yet recruiting | Breast Neoplasms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935317) |
| November 13, 2026 | NCT07935070 | Written Exposure Therapy for Childbirth-related Post-Traumatic Stress | Brigham and Women's Hospital | Not applicable | Recruiting | PTSD (Childbirth-Related), PTSD - Post Traumatic Stress Disorder, PTSD | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935070) |
| November 13, 2026 | NCT07934875 | Understanding Vape Counter-Marketing Study | Boston Children's Hospital | Not applicable | Not yet recruiting | E-Cigarette Use, E-cigarette Use/Vaping Prevention, Vaping Teens, Vaping, Adolescent Behavior, Nicotine, Tobacco | 2,556 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934875) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 12, 2026 | NCT07931170 | Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study | Pediatric Nephrology Research Consortium | Observational | Recruiting | IgA Nephropathy (IgAN), IgA Vasculitis, Idiopathic Immune Complex Glomerulonephritis, C3 Glomerulopathy, Membranous... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931170) |
| November 12, 2026 | NCT07931001 | Longitudinal Assessment of Biomarkers Among Patients With MDD | Massachusetts General Hospital | Observational | Recruiting | Major Depressive Disorder (MDD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931001) |
| November 10, 2026 | NCT07928388 | Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-Deficiency | Medicure | Phase 3 | Recruiting | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928388) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 10, 2026 | NCT07927491 | Surgical Window Study of CM93 in Subjects With Recurrent Glioblastoma (rGBM) | NYU Langone Health | Phase 1 | Not yet recruiting | Recurrent Glioblastoma With EGFR Mutation | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927491) |
| November 9, 2026 | NCT07926347 | Functional Reorganization and Recovery of the Language and Domain-general Multiple Demand Systems in Aphasia | Boston University Charles River Campus | Not applicable | Recruiting | Aphasia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926347) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 9, 2026 | NCT07925333 | Lifileucel (TIL) Therapy After PD-1 Blockade Failure in Kidney Cancer | Beth Israel Deaconess Medical Center | Phase 2 | Not yet recruiting | Kidney Cancers, Renal Cell Carcinoma (Kidney Cancer) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925333) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Massachusetts General Hospital | Boston | 692 |
| Dana-Farber Cancer Institute | Boston | 365 |
| Brigham and Women's Hospital | Boston | 362 |
| Beth Israel Deaconess Medical Center | Boston | 273 |
| Boston Children's Hospital | Boston | 246 |
| Dana Farber Cancer Institute | Boston | 236 |
| Tufts Medical Center | Boston | 124 |
| Boston Medical Center | Boston | 103 |
| Massachusetts General Hospital Cancer Center | Boston | 57 |
| Baystate Medical Center | Springfield | 38 |
| McLean Hospital | Belmont | 32 |
| VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA | Boston | 31 |
| UMass Memorial Medical Center - University Campus | Worcester | 30 |
| Brigham & Women's Hospital | Boston | 30 |
| University of Massachusetts Chan Medical School | Worcester | 30 |
| Lahey Clinic | Burlington | 29 |
| Lahey Hospital and Medical Center | Burlington | 24 |
| Joslin Diabetes Center | Boston | 22 |
| Northeastern University | Boston | 20 |
| Boston University | Boston | 20 |
| Lahey Clinic Peabody | Peabody | 20 |
| University of Massachusetts Memorial Medical Center | Worcester | 18 |
| Massachusetts Eye and Ear | Boston | 18 |
| UMass Memorial Medical Center | Worcester | 17 |
| Lucida Clinical Trials | New Bedford | 16 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 50 |
| Phase 1 | 290 |
| Phase 1/2 | 264 |
| Phase 2 | 544 |
| Phase 2/3 | 66 |
| Phase 3 | 533 |
| Phase 4 | 113 |
| Not applicable | 1,003 |
| Observational | 566 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 133 |
| Carcinoma, Non-Small-Cell Lung | 116 |
| Neoplasms | 114 |
| Lung Neoplasms | 84 |
| Colorectal Neoplasms | 78 |
| Ovarian Neoplasms | 72 |
| Prostatic Neoplasms | 71 |
| Depression | 70 |
| Neoplasm Metastasis | 70 |
| Endometrial Neoplasms | 60 |
| Recurrence | 57 |
| Obesity | 57 |
| Depressive Disorder, Major | 53 |
| Leukemia, Myeloid, Acute | 53 |
| Pancreatic Neoplasms | 52 |
| Heart Failure | 52 |
| Multiple Myeloma | 52 |
| Alzheimer Disease | 51 |
| Squamous Cell Carcinoma of Head and Neck | 47 |
| Stomach Neoplasms | 44 |
| Cardiovascular Diseases | 38 |
| Anxiety Disorders | 38 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 36 |
| Lymphoma | 36 |
| Urinary Bladder Neoplasms | 35 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Massachusetts General Hospital | 365 |
| Brigham and Women's Hospital | 167 |
| Dana-Farber Cancer Institute | 117 |
| Boston Children's Hospital | 109 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 65 |
| Beth Israel Deaconess Medical Center | 64 |
| National Cancer Institute (NCI) | 62 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 60 |
| VA Office of Research and Development | 39 |
| University of Massachusetts, Worcester | 35 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 34 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 30 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 30 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 29 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 28 |
| Boston University Charles River Campus | 28 |
| Boston Medical Center | 28 |
| Mclean Hospital | 27 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 24 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 24 |
| Tufts Medical Center | 21 |
| Spaulding Rehabilitation Hospital | 21 |
| Boston University | 21 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 21 |
| Massachusetts Eye and Ear Infirmary | 20 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Massachusetts

- [Art restoration companies in Massachusetts, United States](https://specstream.ai/data/businesses/art-restoration-companies/massachusetts-united-states)
- [Bakeries in Massachusetts, United States](https://specstream.ai/data/businesses/bakeries/massachusetts-united-states)
- [Breakfast and brunch restaurants in Massachusetts, United States](https://specstream.ai/data/businesses/breakfast-and-brunch-restaurants/massachusetts-united-states)
- [Career counseling services in Massachusetts, United States](https://specstream.ai/data/businesses/career-counseling-services/massachusetts-united-states)
- [Clothing companies in Massachusetts, United States](https://specstream.ai/data/businesses/clothing-companies/massachusetts-united-states)
- [Court reporters in Massachusetts, United States](https://specstream.ai/data/businesses/court-reporters/massachusetts-united-states)
